Clear Street’s Biofrontera BFRIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$364 Buy
9,044
+100
+1% +$5 ﹤0.01% 1062
2025
Q4
$805 Hold
8,944
﹤0.01% 876
2025
Q3
$931 Sell
8,944
-300
-3% -$38 ﹤0.01% 777
2025
Q2
$972 Sell
9,244
-200
-2% -$17 ﹤0.01% 611
2025
Q1
$569 Sell
9,444
-705
-7% -$53 ﹤0.01% 511
2024
Q4
$616 Sell
10,149
-640
-6% -$43 ﹤0.01% 508
2024
Q3
$324 Buy
10,789
+100
+0.9% +$4 ﹤0.01% 645
2024
Q2
$407 Hold
10,689
﹤0.01% 700
2024
Q1
$723 Sell
10,689
-200
-2% -$6 ﹤0.01% 672
2023
Q4
$109 Hold
10,889
﹤0.01% 757
2023
Q3
$425 Buy
10,889
+348
+3% +$31 ﹤0.01% 959
2023
Q2
$1.16K Sell
10,541
-399
-4% -$64 ﹤0.01% 1040
2023
Q1
$2.68K Hold
10,940
﹤0.01% 805
2022
Q4
$2K Sell
10,940
-1,850
-14% -$748 ﹤0.01% 827
2022
Q3
$4K Hold
12,790
﹤0.01% 830
2022
Q2
$9K Buy
+12,790
New +$14.1K ﹤0.01% 571

Other funds holding BFRIW

Clear Street's BFRIW Position: Q1 2026 in Review

Clear Street increased its Biofrontera (BFRIW) stake by 1.1% in Q1 2026, buying an estimated $5 and bringing the position to 9,044 shares worth $364. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Clear Street first reported a position in BFRIW in Q2 2022 and has held it in 16 quarters since. The position peaked at $9K in Q2 2022. 6 funds tracked by Wall St. Rank hold BFRIW as of Q1 2026.

  • Clear Street held 9,044 shares of Biofrontera worth $364 as of Q1 2026.
  • Clear Street bought 100 Biofrontera shares in Q1 2026, an estimated $5.
  • Biofrontera made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1062 holding.
  • Clear Street first reported a position in Biofrontera in Q2 2022 and has held it in 16 quarters since.
  • Clear Street's Biofrontera position peaked at $9K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.